Statins may lower mortality risk in kidney cancer patients

05/8/2013 | HealthDay News

An analysis of data from more than 900 patients who underwent surgery for renal cell carcinoma showed that statin use was associated with a lower risk of cancer progression and death. Nearly four years after surgery, 10% of statin users died of kidney cancer compared with 17% of nonusers, researchers found. The findings were reported at the annual meeting of the American Urological Association.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA